Loading…
State-of-the-art of small molecule inhibitors of the TAM family: The point of view of the chemist
The TAM family of tyrosine kinases receptors (Tyro3, Axl and Mer) is implicated in cancer development, autoimmune reactions and viral infection and is therefore emerging as an effective and attractive therapeutic target. To date, only a few small molecules have been intentionally designed to block t...
Saved in:
Published in: | European journal of medicinal chemistry 2015-11, Vol.105, p.220-237 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The TAM family of tyrosine kinases receptors (Tyro3, Axl and Mer) is implicated in cancer development, autoimmune reactions and viral infection and is therefore emerging as an effective and attractive therapeutic target. To date, only a few small molecules have been intentionally designed to block the TAM kinases, while most of the inhibitors were developed for blocking different protein kinases and then identified through selectivity profile studies. This minireview will examine in terms of chemical structure the different compounds able to act on either one, two or three TAM kinases with details about structure–activity relationships, drug-metabolism and pharmacokinetics properties where they exist.
[Display omitted]
•Small molecules as inhibitors of Tyro3, Axl and Mer tyrosine kinases.•Crystal structures of Tyro3 and Mer are known.•SARs and DMPK properties of inhibitors targeting TAM kinases. |
---|---|
ISSN: | 0223-5234 1768-3254 |
DOI: | 10.1016/j.ejmech.2015.10.003 |